Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5422531 | 0.92 | CHRM2 (0.42) | CHRM2CHRM4CHRM3SLC6A3POLB | |
| SCHEMBL9967101 | 0.92 | CHRM2 (0.42) | CHRM2CHRM4CHRM3SLC6A3POLB | |
| SCHEMBL18913409 | 0.92 | CHRM2 (0.42) | CHRM2CHRM4CHRM3SLC6A3POLB | |
| Hydrochloric Acid SCHEMBL4386858 | 0.90 | SLC6A3 (0.41) | CHRM2CHRM4CHRM3SLC6A3POLB | |
| SCHEMBL18628997 | 0.82 | POLB (0.53) | SLC6A3POLB | |
| SCHEMBL34462074 | 0.82 | POLB (0.53) | SLC6A3POLB | |
| SCHEMBL17518655 | 0.82 | POLB (0.53) | SLC6A3POLB | |
| SCHEMBL1105066 | 0.82 | POLB (0.53) | SLC6A3POLB | |
| SCHEMBL417319 | 0.81 | CHRM2 (0.47) | CHRM2CHRM4CHRM3CHRNB2CHRNA4 | |
| SCHEMBL30849529 | 0.81 | CHRM2 (0.47) | CHRM2CHRM4CHRM3CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017133665-A1 | 6,7-DIAZAINDAZOLE AND 6,7-DIAZAINDOLE DERIVATIVES AND USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA THEREOF | SAVIRA PHARMACEUTICALS GMBH (AT) | 2017-08-10 | — | — | WO | disclosed |
| WO-2012083117-A1 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-06-21 | — | — | WO | disclosed |